Genenta Science S.p.A. (GNTA) annual income statement — 7-year revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - |
| Cost of Goods Sold | 26.97K | 46.51K | 41.7K | 6K | 5.1K | 1.77K | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - |
| Gross Profit | -26.97K | -46.51K | -41.7K | -6K | -5.1K | -1.77K | 0 |
| Gross Margin % | - | - | - | - | - | - | - |
| Gross Profit Growth % | 42% | -11.52% | -595.55% | -17.66% | -188.24% | - | - |
| Operating Expenses | 6.32M | 10.15M | 11.48M | 10.78M | 5.92M | 5.2M | 4.56M |
| OpEx % of Revenue | - | - | - | - | - | - | - |
| Selling, General & Admin | 3.72M | 5.13M | 5.12M | 5.57M | 2.39M | 837.35K | 908.43K |
| SG&A % of Revenue | - | - | - | - | - | - | - |
| Research & Development | 2.59M | 5.03M | 6.36M | 5.21M | 3.53M | 4.36M | 3.65M |
| R&D % of Revenue | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -6.34M | -10.2M | -11.53M | -10.79M | -5.93M | -5.2M | -4.56M |
| Operating Margin % | - | - | - | - | - | - | - |
| Operating Income Growth % | 37.81% | 11.51% | -6.87% | -81.93% | -13.97% | -14.11% | - |
| EBITDA | -6.32M | -10.15M | -11.48M | -10.78M | -5.92M | -5.2M | -4.56M |
| EBITDA Margin % | - | - | - | - | - | - | - |
| EBITDA Growth % | 37.79% | 11.59% | -6.54% | -81.98% | -13.91% | -14.07% | - |
| D&A (Non-Cash Add-back) | 26.97K | 46.51K | 41.7K | 6K | 5.1K | 1.77K | 0 |
| EBIT | -5.89M | -9.31M | -11.44M | -8.28M | -5.76M | -5.2M | -4.56M |
| Net Interest Income | 584.49K | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 968.7K | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 384.21K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 71K | 889.79K | 85.95K | 2.51M | 164.65K | -1.66K | 26.4K |
| Pretax Income | -6.27M | -9.31M | -11.44M | -8.28M | -5.76M | -5.2M | -4.53M |
| Pretax Margin % | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -6.27M | -9.31M | -11.44M | -8.28M | -5.76M | -5.2M | -4.53M |
| Net Margin % | - | - | - | - | - | - | - |
| Net Income Growth % | 32.63% | 18.62% | -38.18% | -43.64% | -10.77% | -14.81% | - |
| Net Income (Continuing) | -6.27M | -9.31M | -11.44M | -8.28M | -5.76M | -5.2M | -4.53M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.33 | -0.49 | -0.64 | -0.47 | -0.31 | -0.31 | -0.25 |
| EPS Growth % | 32.65% | 23.44% | -36.17% | -51.61% | 0% | -24% | - |
| EPS (Basic) | -0.33 | -0.49 | -0.64 | -0.47 | -0.31 | -0.31 | -0.25 |
| Diluted Shares Outstanding | 19.71M | 18.27M | 18.22M | 18.22M | 18.22M | 18.12M | 18.12M |
| Basic Shares Outstanding | 19.71M | 18.27M | 18.22M | 18.22M | 18.22M | 18.12M | 18.12M |
| Dividend Payout Ratio | - | - | - | - | - | - | - |
Quick answers to the most common questions about buying GNTA stock.
For fiscal year 2025, Genenta Science S.p.A. (GNTA) reported total revenue of $0.0M.
Genenta Science S.p.A. (GNTA) reported a net loss of $6.3M for the fiscal year ending 2025.